Press Releases

During convening, WomenAgainstAlzheimer’s launches its bold We Won’t Wait campaign to highlight the economic injustice of the disease on women

May 12, 2016

WASHINGTON, DC, May 13, 2016—WomenAgainstAlzheimer’s – an UsAgainstAlzheimer’s network and a global nonprofit organization that advocates for women – today announced the launch of its bold We Won’t Wait campaign to bring to light the economic injustice that women face when they experience Alzheimer’s either as the patient or the caregiver. The campaign is the first-ever effort to define Alzheimer’s as both an economic as well as a health-related injustice against women, and it is the organization’s next phase in its successful work over the last four years fighting for a cure through a woman’s lens.

Jason Resendez, Director of UsAgainstAlzheimer’s Latino Network, Appointed to AT&T’s Advisory Panel on Access and Aging

May 11, 2016

WASHINGTON, DC, May 12, 2016—Today, UsAgainstAlzheimer’s announced that Jason Resendez, Director of UsAgainstAlzheimer’s Latino Network and the LatinosAgainstAlzheimer’s Coalition, will join AT&T’s Advisory Panel on Access and Aging as an external advisor.

UsAgainstAlzheimer’s Leadership to be Featured Guests on Alzheimer’s Speaks Radio Show Hosted by Lori La Bey

April 26, 2016

UsAgainstAlzheimer’s (UsA2) co-founders, George and Trish Vradenburg, as well as UsA2 network leads Jill Lesser (WomenAgainstAlzheimer’s), Jason Resendez (LatinosAgainstAlzheimer’s), Drew Holzapfel (ResearchersAgainstAlzheimer’s) and Virginia Biggar (ClergyAgainstAlzheimer’s) will be guests on today’s Alzheimer’s Speaks Radio show, hosted by Lori La Bey, at 2 pm EST.

UsAgainstAlzheimer’s Co-founders Honored at Sixth Annual Great Ladies Luncheon & Fashion Show

April 12, 2016

WASHINGTON, DC – UsAgainstAlzheimer’s (UsA2) co-founders George and Trish Vradenburg were honored today at the Sixth Annual Great Ladies Luncheon & Fashion Show, presented by the Alzheimer’s Drug Discovery Foundation (ADDF) and Neiman Marcus Mazza Gallerie, for their many contributions to ending Alzheimer’s disease. The event, emceed by Fox News television anchor Chris Wallace, featured a presentation on “New Frontiers in Alzheimer’s Prevention and Treatment,” as well as a runway show by Oscar de la Renta.

UsAgainstAlzheimer's Statement on Eli Lilly and Company and AstraZeneca's BACE Inhibitor Drug for Alzheimer's Clinical Trial

April 8, 2016

WASHINGTON, DC—Following is a statement by George Vradenburg, chairman of UsAgainstAlzheimer's, on the announcement that Eli Lilly and Company and AstraZeneca's experimental BACE inhibitor drug for Alzheimer's is advancing to Phase 3 clinical trials

Why 2020?

UsAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.